Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready
Terasaki Institute For Biomedical Innovation has 7 pending office actions in Biotechnology & Pharmaceuticals. The docket involves 7 distinct examiners and 7 distinct art units, so the recorded matters are distributed across separate examiner and technical assignments.
HUMPHRIES, NICHOLAS ADAM is the listed busiest examiner, with 1 pending action. The data does not show examiner concentration, which makes matter-level preparation important. Counsel should evaluate claim language, written-description support, and prior-art responses independently for each art unit, while preserving consistent terminology across the portfolio where the disclosures overlap.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUMPHRIES, NICHOLAS ADAM | 1 | 34.2% | +76.6% |
| WISTNER, SARAH CLINKSCALES | 1 | 26.7% | +73.0% |
| GHALI, ISIS A D | 1 | 27.9% | +41.6% |
| TRAN, LIEN THUY | 1 | 28.7% | +26.5% |
| MERCHLINSKY, JOSEPH CULLEN | 1 | 5.9% | -6.3% |
| WESTON, ALYSSA G | 1 | 59.5% | +49.0% |
| DIVIESTI, KARLA ISOBEL | 1 | 3.2% | +16.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 127d overdue |
| 18280998 | METHODS AND SYSTEMS OF PREPARING CULTIVATED MEAT FROM BLOOD OR CELLULAR BIOMASS | DIVIESTI, KARLA ISOBEL | 44d overdue |
| 18876773 | CELL GROWTH SUPPLEMENTS USING DAIRY-BASED MATERIALS | HUMPHRIES, NICHOLAS ADAM | — |
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | — |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | — |
| 18280994 | CONSTRUCTS COMPRISING FIBRIN OR OTHER BLOOD PRODUCTS FOR MEAT CULTIVATION AND OTHER APPLICATIONS | MERCHLINSKY, JOSEPH CULLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 127d overdue |
| 18280998 | METHODS AND SYSTEMS OF PREPARING CULTIVATED MEAT FROM BLOOD OR CELLULAR BIOMASS | DIVIESTI, KARLA ISOBEL | 44d overdue |
| 18876773 | CELL GROWTH SUPPLEMENTS USING DAIRY-BASED MATERIALS | HUMPHRIES, NICHOLAS ADAM | — |
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | — |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | — |
| 18281032 | PRODUCTION OF HEME FOR CELL-BASED MEAT PRODUCTS | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| 1616 | 1 |
| 1611 | 1 |
| 1793 | 1 |
| 1791 | 1 |
| 1633 | 1 |
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18876773 | CELL GROWTH SUPPLEMENTS USING DAIRY-BASED MATERIALS | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | 1616 | §102§103§112 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | 1611 | §103§112 | Final Rejection | — | Pending | Oct 10, 2023 |
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 1793 | §102§112 | Non-Final OA | 127d overdue | Pending | Sep 08, 2023 |
| 18280994 | CONSTRUCTS COMPRISING FIBRIN OR OTHER BLOOD PRODUCTS FOR MEAT CULTIVATION AND OTHER APPLICATIONS | MERCHLINSKY, JOSEPH CULLEN | 1791 | §103 | Final Rejection | — | Pending | Sep 08, 2023 |
| 18281032 | PRODUCTION OF HEME FOR CELL-BASED MEAT PRODUCTS | WESTON, ALYSSA G | 1633 | §103§112DP | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18280998 | METHODS AND SYSTEMS OF PREPARING CULTIVATED MEAT FROM BLOOD OR CELLULAR BIOMASS | DIVIESTI, KARLA ISOBEL | 1792 | §103 | Non-Final OA | 44d overdue | Pending | Sep 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTerasaki Institute For Biomedical Innovation has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Nicholas Adam Humphries has the most, with 1 of Terasaki Institute For Biomedical Innovation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
